Document is current

Any future updates will be listed below

Real-World Clinical and Economic Outcomes of Liraglutide Versus Sitagliptin in Patients with Type 2 Diabetes Mellitus in the United States

Crossref DOI link: https://doi.org/10.1007/s13300-014-0084-9

Published Online: 2014-09-26

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark